Valbiotis

La Rochelle, France

Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients.

$9.8M raised

Nov 2022

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Valbiotis raised?

Valbiotis has raised $9.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2022.

Who are Valbiotis's investors?

Valbiotis's investors include Sofimac Investment Managers.

Where is Valbiotis headquartered?

Valbiotis is headquartered in La Rochelle, France.

What does Valbiotis do?

Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients.

What stage is Valbiotis at?

Valbiotis is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 8, 2022.

MLA

"Valbiotis — Funding & Investors." VCBacked, November 8, 2022, https://www.vcbacked.co/company/valbiotis. Accessed July 2, 2026.

APA

VCBacked. (2022). Valbiotis — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/valbiotis

Wikipedia (cite web)

{{cite web |title=Valbiotis — Funding & Investors |url=https://www.vcbacked.co/company/valbiotis |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 8, 2022.